tiprankstipranks
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
US Market

InnoCan Pharma (INNPF) Income Statement

Compare
13 Followers

InnoCan Pharma Income Statement

Last quarter (Q3 2024), InnoCan Pharma's total revenue was $8.62M, an increase of 111.22% from the same quarter last year. In Q3, InnoCan Pharma's net income was $-290.00K. See InnoCan Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 13.66M$ 2.56M$ 196.00K$ 8.00K$ 0.00
Gross Profit
$ 11.98M$ 2.11M$ 121.00K$ 3.00K$ 0.00
Operating Expenses
$ 8.18M$ 8.37M$ 7.60M$ 4.73M$ 3.00M
Depreciation and Amortization
$ 33.00K$ 35.00K$ 43.00K$ 40.00K$ 23.00K
EBITDA
$ -3.77M$ -3.85M$ -10.04M$ -9.90M$ -2.98M
Operating Income
$ 3.80M$ -6.27M$ -7.48M$ -4.72M$ -3.00M
Other Income/Expenses
$ -7.84M$ 2.38M$ -2.61M$ -5.23M$ -334.00K
Pretax Income
$ -4.03M$ -3.89M$ -10.09M$ -9.95M$ -3.33M
Net Income
$ -4.70M$ -3.89M$ -10.06M$ -15.18M$ -3.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.02$ -0.02$ -0.04$ -0.09$ -0.03
Diluted EPS
$ -0.02$ -0.02$ -0.04$ -0.09$ -0.03
Weighted Average Shares Outstanding
257.01M 248.95M 224.54M 162.02M 120.64M
Weighted Average Shares Outstanding (Diluted)
257.00M 248.95M 224.54M 162.02M 120.64M
Currency in USD

InnoCan Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis